The future role for colposcopy in Europe

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Colposcopy's diagnostic performance can limit cervical screening effectiveness.
• Colposcopy is crucial for assessing high-risk women for cervical cancer.
• The role and provision of colposcopy vary significantly across Europe.

Purpose of the Study:

• To analyze the impact of human papillomavirus (HPV) vaccination and HPV-based screening on colposcopy services in Europe.
• To discuss strategies for maintaining or improving colposcopy standards amidst evolving screening protocols.
• To address the anticipated changes in patient profiles and colposcopic management.

Main Methods:

• Review of current colposcopy practices in Europe.
• Analysis of projected changes in cervical intraepithelial neoplasia (CIN) and cervical cancer incidence.
• Consideration of varying national screening program implementations.

Main Results:

• HPV vaccination may decrease cervical intraepithelial neoplasia grade 3 prevalence.
• HPV-based screening is expected to reduce CIN 3 and cervical cancer incidence compared to cytology.
• An increase in women with minor abnormalities and glandular disease detected at colposcopy is anticipated with HPV screening.

Conclusions:

• Colposcopy standards can be maintained or improved despite varied screening availability.
• Adapting colposcopy services is essential to manage changes driven by HPV vaccination and HPV-based screening.
• Quality assurance development is crucial for supporting these program changes across Europe.